Cargando…
Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifes...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061484/ https://www.ncbi.nlm.nih.gov/pubmed/33911290 http://dx.doi.org/10.4103/ijd.IJD_602_20 |
_version_ | 1783681576265056256 |
---|---|
author | Kumar, Piyush Chatterjee, Mitali Das, Nilay Kanti |
author_facet | Kumar, Piyush Chatterjee, Mitali Das, Nilay Kanti |
author_sort | Kumar, Piyush |
collection | PubMed |
description | Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifests as a variable combination of hypopigmented patches, erythematous succulent papulo-plaques, and nodular lesions on the face and upper body and sometimes extending on the extremities, genitalia, and tongue. Atypical morphology and presentations are not uncommon, especially in endemic areas, which include photosensitivity, verrucous, hypertrophic, xanthomatous, and ulcerative lesions. Recognition of spectrum of mucocutaneous changes helps physicians in early initiation of treatment and in reducing disease transmission in the community. The differential diagnosis depends on the pattern of manifestations, but lepromatous leprosy is the closest mimicker. Since PKDL does not cause significant morbidity, at least initially, but the affected patients continue to act as a reservoir of the disease, active case detection is required to identify cases early to control the disease transmission in the community. |
format | Online Article Text |
id | pubmed-8061484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-80614842021-04-27 Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis Kumar, Piyush Chatterjee, Mitali Das, Nilay Kanti Indian J Dermatol IJD Symposium Post kala-azar dermal leishmaniasis (PKDL) is a mucocutaneous disease usually seen in apparently cured, inadequately treated or untreated cases of visceral leishmaniasis and is endemic to many parts of India, Nepal, Bangladesh, and eastern Africa (Sudan, Ethiopia, Kenya). The disease usually manifests as a variable combination of hypopigmented patches, erythematous succulent papulo-plaques, and nodular lesions on the face and upper body and sometimes extending on the extremities, genitalia, and tongue. Atypical morphology and presentations are not uncommon, especially in endemic areas, which include photosensitivity, verrucous, hypertrophic, xanthomatous, and ulcerative lesions. Recognition of spectrum of mucocutaneous changes helps physicians in early initiation of treatment and in reducing disease transmission in the community. The differential diagnosis depends on the pattern of manifestations, but lepromatous leprosy is the closest mimicker. Since PKDL does not cause significant morbidity, at least initially, but the affected patients continue to act as a reservoir of the disease, active case detection is required to identify cases early to control the disease transmission in the community. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8061484/ /pubmed/33911290 http://dx.doi.org/10.4103/ijd.IJD_602_20 Text en Copyright: © 2021 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | IJD Symposium Kumar, Piyush Chatterjee, Mitali Das, Nilay Kanti Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title | Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title_full | Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title_fullStr | Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title_full_unstemmed | Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title_short | Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis |
title_sort | post kala-azar dermal leishmaniasis: clinical features and differential diagnosis |
topic | IJD Symposium |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061484/ https://www.ncbi.nlm.nih.gov/pubmed/33911290 http://dx.doi.org/10.4103/ijd.IJD_602_20 |
work_keys_str_mv | AT kumarpiyush postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis AT chatterjeemitali postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis AT dasnilaykanti postkalaazardermalleishmaniasisclinicalfeaturesanddifferentialdiagnosis |